Dogwood Therapeutics, Inc. Other Comprehensive Income (Loss), Net of Tax
Dogwood Therapeutics, Inc. (DWTX) reported Other Comprehensive Income (Loss), Net of Tax of -$3.86 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-03-18
- Dogwood Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was -$3.86M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|
| 2024-12-31 | -$3.86M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |